Aspire BioPharma
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | 0 | 0 | |
EBITDA | -11,075 | -242 | -96 |
Net Income | -11,966 | -243 | -96 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | 479 | -495 | -105 |
Cash | 3 | 16 | 19 |
Basic Shares | 45,937 | 45,937 | 45,937 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | 0 | 0 | |
EBITDA | -358 | -596 | |
Net Income | -12,537 | -359 | -597 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -265 | 11 | -5,038 |
Cash | 3 | 11 | |
Basic Shares | 46,007 | 45,937 | 45,937 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.15 |
2024-09-30 | -$0.06 |
2024-06-30 | -$0.07 |
2024-03-31 | -$0.27 |
